| Current strategies to circumvent the antiviral immunity to optimize cancer virotherapy DH Shin, T Nguyen, B Ozpolat, F Lang, M Alonso, C Gomez-Manzano, ... Journal for immunotherapy of cancer 9 (4), 2021 | 40 | 2021 |
| Localized treatment with oncolytic adenovirus delta-24-RGDOX induces systemic immunity against disseminated subcutaneous and intracranial melanomas H Jiang, DH Shin, TT Nguyen, J Fueyo, X Fan, V Henry, CC Carrillo, Y Yi, ... Clinical Cancer Research 25 (22), 6801-6814, 2019 | 40 | 2019 |
| Reshaping the tumor microenvironment with oncolytic viruses, positive regulation of the immune synapse, and blockade of the immunosuppressive oncometabolic circuitry TT Nguyen, DH Shin, S Sohoni, SK Singh, Y Rivera-Molina, H Jiang, ... Journal for immunotherapy of cancer 10 (7), 2022 | 34 | 2022 |
| GITRL-armed Delta-24-RGD oncolytic adenovirus prolongs survival and induces anti-glioma immune memory Y Rivera-Molina, H Jiang, J Fueyo, T Nguyen, DH Shin, G Youssef, X Fan, ... Neuro-Oncology Advances 1 (1), vdz009, 2019 | 33 | 2019 |
| Tune up in situ autovaccination against solid tumors with oncolytic viruses T Nguyen, NG Avci, DH Shin, N Martinez-Velez, H Jiang Cancers 10 (6), 171, 2018 | 18 | 2018 |
| Remission of liquid tumors and SARS-CoV-2 infection: A literature review DH Shin, A Gillard, A Van Wieren, C Gomez-Manzano, J Fueyo Molecular Therapy-Oncolytics 26, 135-140, 2022 | 10 | 2022 |
| Chimeric oncolytic adenovirus evades neutralizing antibodies from human patients and exhibits enhanced anti-glioma efficacy in immunized mice DH Shin, H Jiang, AG Gillard, D Kim, X Fan, SK Singh, TT Nguyen, ... Molecular Therapy 32 (3), 722-733, 2024 | 9 | 2024 |
| Targeting innate immunity in glioma therapy AG Gillard, DH Shin, LA Hampton, A Lopez-Rivas, A Parthasarathy, ... International journal of molecular sciences 25 (2), 947, 2024 | 3 | 2024 |
| The Role of Anti-Viral Immune Response on the Therapeutic Efficacy of Oncolytic Virotherapy for High-Grade Gliomas DH Shin PhD | | 2024 |
| Adjuvant therapy with oncolytic adenovirus Delta-24-RGDOX after intratumoral adoptive T-cell therapy promotes antigen spread to sustain systemic antitumor immunity H Jiang, DH Shin, Y Yi, X Fan, J Gumin, J He, AG Gillard, FF Lang, ... Cancer Research Communications 3 (6), 1118-1131, 2023 | | 2023 |
